Publications by authors named "Alison R Walker"

23Publications

The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent.

Clin Lymphoma Myeloma Leuk 2020 Aug 21. Epub 2020 Aug 21.

Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.08.013DOI Listing
August 2020

Phase I study of AR-42 and decitabine in acute myeloid leukemia.

Leuk Lymphoma 2020 06 8;61(6):1484-1492. Epub 2020 Feb 8.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1719095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375689PMC
June 2020

Predictive performance of early warning scores in acute leukemia patients receiving induction chemotherapy.

Leuk Lymphoma 2018 06 13;59(6):1498-1500. Epub 2017 Sep 13.

c Divison of Hematology , The Ohio State University , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1376744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132216PMC
June 2018

A comparison of toxicities in acute myeloid leukemia patients with and without renal impairment treated with decitabine.

J Oncol Pharm Pract 2018 Jun 26;24(4):290-298. Epub 2017 Mar 26.

4 Department of Internal Medicine, Division of Hematology, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217702213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154947PMC
June 2018

Dying a fiery death: pyroptosis in MDS.

Authors:
Alison R Walker

Blood 2016 12;128(25):2875-2877

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-10-746719DOI Listing
December 2016

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.

J Natl Compr Canc Netw 2014 Apr;12(4):527-34

From the aDivision of Hematology, Department of Internal Medicine, and bDepartment of Molecular, Cellular, and Developmental Biology, The Ohio State University and The Ohio State Comprehensive Cancer Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0057DOI Listing
April 2014

Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma.

Cancer Invest 2008 May;26(4):431-3

University of Rochester, Hematology/Oncology, Rochester, New York 14642, USA. alison

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900701809068DOI Listing
May 2008